Blood platelet test for earlier ALS diagnosis
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at platelets (tiny blood cells that help clotting) in people with ALS to find a way to diagnose the disease earlier. If you've been recently diagnosed with ALS or another motor neuron disease, your blood sample could help researchers develop a simple test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with ALS or another motor neuron disease within the last 3 months
- For ALS: your symptoms started less than 2 years ago
- You are not taking blood thinners (except low-dose aspirin up to 160 mg per day)
- You are not pregnant or breastfeeding
- You do not have a known genetic cause for ALS
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for biological markers in the blood that can help monitor how ALS progresses and potentially detect it earlier. By participating, you may help improve future diagnosis and care for ALS patients.
This study screens people with ALS to see if they might qualify for future gene-targeted treatments. It helps match you to trials that may be a good fit for your genetic type.
This study looks at a protein called P2X4 on immune cells in your blood to see if it can help diagnose ALS. You would give a blood sample to help researchers find a new way to identify ALS.
This study looks for early signs of ALS in people with genetic risk, healthy controls, and people with early symptoms. It aims to find markers that could help diagnose ALS sooner.
This study looks at a blood test to help doctors diagnose ALS (Lou Gehrig's disease). It tests a protein called neurofilaments that may show nerve damage. The study is for people suspected of having ALS, and the blood sample is taken as part of normal care.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
Hear when a new ALS (Amyotrophic Lateral Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.